PNC Financial Services Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Hold
963
– – ﹤0.01% 2890
2026
Q1
$100K Hold
963
– – ﹤0.01% 2819
2025
Q4
$99.4K Sell
963
-51
-5% -$4.96K ﹤0.01% 2809
2025
Q3
$91.6K Buy
1,014
+764
+306% +$66.9K ﹤0.01% 2860
2025
Q2
$22K Hold
250
– – ﹤0.01% 3528
2025
Q1
$22.8K Hold
250
– – ﹤0.01% 3482
2024
Q4
$21.6K Buy
+250
New +$22.6K ﹤0.01% 3497
2020
Q3
– Sell
-350
Closed -$22K – 4016
2020
Q2
$22K Hold
350
– – ﹤0.01% 3160
2020
Q1
$19K Hold
350
– – ﹤0.01% 3139
2019
Q4
$22K Buy
+350
New +$21.1K ﹤0.01% 3288
2016
Q2
– Sell
-2,072
Closed -$119K – 4539
2016
Q1
$119K Hold
2,072
– – ﹤0.01% 2400
2015
Q4
$135K Hold
2,072
– – ﹤0.01% 2297
2015
Q3
$130K Hold
2,072
– – ﹤0.01% 2366
2015
Q2
$147K Sell
2,072
-300
-13% -$21.6K ﹤0.01% 2421
2015
Q1
$167K Buy
2,372
+300
+14% +$20.3K ﹤0.01% 2362
2014
Q4
$133K Hold
2,072
– – ﹤0.01% 2311
2014
Q3
$132K Sell
2,072
-135
-6% -$8.36K ﹤0.01% 2232
2014
Q2
$137K Buy
2,207
+135
+7% +$8.02K ﹤0.01% 2107
2014
Q1
$121K Hold
2,072
– – ﹤0.01% 2131
2013
Q4
$110K Hold
2,072
– – ﹤0.01% 2144
2013
Q3
$99K Hold
2,072
– – ﹤0.01% 2181
2013
Q2
$94K Buy
+2,072
New +$95.8K ﹤0.01% 2145

Other funds holding PPH

PNC Financial Services Group's PPH Position: Q2 2026 in Review

PNC Financial Services Group held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 963 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2890.

PNC Financial Services Group first reported a position in PPH in Q2 2013 and has held it in 22 quarters since. The position peaked at $167K in Q1 2015. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • PNC Financial Services Group held 963 shares of VanEck Pharmaceutical ETF worth $105K as of Q2 2026.
  • PNC Financial Services Group left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2890 holding.
  • PNC Financial Services Group first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 22 quarters since.
  • PNC Financial Services Group's VanEck Pharmaceutical ETF position peaked at $167K in Q1 2015.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.